KARYON-CTT
Karyon, Ltd. develops peptides into carriers for use in cancer diagnostics, imaging, and therapy. It offers Karyon Targeting Unit, a synthetic peptide that targets specific tumor tissue. The company engages in the areas of cancer biology and cell growth regulation, angiogenesis, biochemistry, peptide chemistry, organic syntheses and immunohistochemistry. Karyon, Ltd. was founded in 2001 and is based in Helsinki, Finland. As of May 6, 2008, Karyon Ltd. operates as a subsidiary of Isogenica Limited.
KARYON-CTT
Industry:
Biotechnology Health Diagnostics
Founded:
2001-01-01
Address:
Helsinki, Southern Finland, Finland
Country:
Finland
Website Url:
http://www.karyon.fi
Status:
Closed
Contact:
358 9319 36400
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Holtsch Med
Holtsch Med develops reliable medical devices and drugs for the prevention, diagnosis, and healing of diseases.
MedEvent
MedEvent sells medical devices in the area of diagnostics and therapy for prostate cancer.
Protea Biopharma
Protea biopharma is a biotechnology company specializes in developing advanced diagnostics and therapeutics for chronic immune diseases.
Current Employees Featured
